LINC01133 and lung adenocarcinoma: LINC01133 could promote the malignant behaviors in several tumor, such as lung adenocarcinoma [28], hepatocellular carcinoma [29], triple-negative breast cancer [30] and nasopharyngeal carcinoma [31].